 |
|
|
| |
PEARL III: SVR ≥99% AFTER 12 WKS OF ABT-450/R/267 + ABT-333 ± RBV IN TREATMENT-NAIVE HCV GT1B INFECTION
|
| |
| |
Reported by Jules Levin
CROI 2014
Boston
Peter Ferenci, Anders Nyberg, Pedram Enayati, David Bernstein, Yaacov Baruch, Florin Alexandru Caruntu, Vladimir Chulanov, Ewa Janczewska, Ziad Younes, Rui T Marinho, Giuliano Rizzardini, Judit Gervain, Ramon Planas, Christophe Moreno, Wangang Xie, Daniel Cohen, Martin King, Thomas Podsadecki, K Rajender Reddy On behalf of PEARL III Investigators
CROI webcast:
http://www.croiwebcasts.org/console/player/22172?mediaType=slideVideo&
|
| |
|
|
|
|
|
